NewAmsterdam's drug shows promise in lowering LDL-C
NewAmsterdam Pharma Company N.V. (NASDAQ: NAMS), a clinical-stage biopharmaceutical firm, saw its shares surge 62% after announcing positive results from its Phase 3 BROADWAY clinical trial. ...
Factbox-US finalizes more than $6.1 billion funding for Micron under CHIPS Act
(Reuters) -The U.S. Department of Commerce has finalized a subsidy of more than $6.1 billion for Micron Technology (NASDAQ: MU ), marking one of the largest government awards to chip c...
Saudi Arabia stocks higher at close of trade; Tadawul All Share up 0.80%
Investing.com – Saudi Arabia stocks were higher after the close on Tuesday, as gains in the Media & Publishing , Petrochemicals and Telecoms & IT sectors led shar...
